RAPP Latest Press Releases

-- October 28, 2026 --

Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement Globe Newswire 6:00 AM

-- October 27, 2026 --

Rapport Announces Proposed Public Offerings of Common Stock and Convertible Notes as well as Concurrent Private Placement Globe Newswire 4:32 PM

-- October 20, 2026 --

Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania Globe Newswire 6:00 AM

-- September 2, 2026 --

Rapport Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- August 24, 2026 --

Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program Globe Newswire 7:00 AM

-- August 5, 2026 --

Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes